AION Labs, a Rehovot-based consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company that will help drug firms improve chances of success in clinical trials

Thousands of doses of the coronavirus treatment arrive, days after Health Ministry's emergency approval of medicine

Daily cases nearly triple in a week; PM said to warn surge may leave hospitals on verge of collapse; Pfizer pill shipment set to arrive; 1st case recorded of both COVID and flu

A third shot of its vaccine 'neutralized the Omicron variant' to levels seen following the second dose, says the pharmaceutical giant in new research

AstraZeneca's Evusheld okayed for those 12 and older who didn't respond adequately to vaccines or who have history of severe allergic reactions to shots

Pfizer, Merck, Teva, Amazon form consortium that runs AION Labs, an Israeli facility that will focus on harnessing artificial intelligence in drug development

Phase III test on 900 participants with mild to moderate coronavirus symptoms finds medication caused statistically significant reduction in severe illness and death

72% of trial patients administered Enherthu showed no progression in their cancer after 12 months, compared to 34.1% of those treated with the current standard of care medication

British-Swedish pharmaceutical company sees 77% reduced risk of developing symptomatic disease

With unwanted AstraZeneca doses on the way, and the majority of the Palestinians not vaccinated, there would seem to be a win-win solution. Except it's not that simple